Marianna Romito
Freiburg, BW 79110, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCR.
Journal: Nature communications
Published: December 17, 2024
CRISPR/Cas9-Based Disease Modeling and Functional Correction of Interleukin 7 Receptor Alpha Severe Combined Immunodeficiency in T-Lymphocytes and Hematopoietic Stem Cells.
Journal: Human gene therapy
Published: January 22, 2024
Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 Infection.
Journal: Biotechnology journal
Published: May 18, 2020
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.
Journal: Nature communications
Published: September 26, 2019
Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.
Journal: Haematologica
Published: April 21, 2019
Genome editing for blood disorders: state of the art and recent advances.
Journal: Emerging topics in life sciences
Published: January 21, 2019
Erratum to: Delivery of Designer Epigenome Modifiers into Primary Human T Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 12, 2018
Delivery of Designer Epigenome Modifiers into Primary Human T Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2018
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells.
Journal: Nucleic acids research
Published: October 17, 2017
Failure to detect DNA-guided genome editing using Natronobacterium gregoryi Argonaute.
Journal: Nature biotechnology
Published: November 29, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026